Access the full text.
Sign up today, get DeepDyve free for 14 days.
G. L. Lilien, A. Rao, S. Kalish (1981)
Bayesian estimation and control of detailing effort in a repeat purchase environment, 27
P. Rossi, R. McCulloch, G. Allenby (1996)
The value of purchase history data in target marketing, 15
D. Byzalov, R. Shachar (2004)
The risk reduction role of advertising, 2
A. Coscelli, M. Shum (2004)
An empirical model of learning and spillovers in new drug entry, 122
G. L. Lilien (1974b)
Application of a modified linear learning model of buyer behavior, 11
F. Gnl, F. Carter, E. Petrova, K. Srinivasan (2001)
Promotion of prescription drugs and its impact on physicians' choice behavior, 65
S. Narayanan, P. Manchanda, P. K. Chintagunta (2005)
Temporal differences in the role of marketing communication for new product categories, 42
P. Manchanda, E. Honka (2005)
The effects and role of direct-to-physician marketing in the pharmaceutical industry: An integrative review, 5
P. Manchanda, P. E. Rossi, P. K. Chintagunta (2004)
Response modeling with nonrandom marketing-mix variables, 41
P. Stoneman (1981)
Intra-firm diffusion, Bayesian learning and profitability, 91
G. Iyer, D. A. Soberman, J. M. Villas-Boas (2005)
The targeting of advertising, 24
G. L. Lilien (1974a)
A modified linear learning model of buyer behavior, 20
(2000)
CDER Report to the Nation: 2000
D. Ackerberg (2003)
Advertising, learning and consumer choice in experience good markets: An empirical examination, 44
C. Heilman, D. Bowman, G. P. Wright (2000)
The evolution of brand preferences and choice behavior of consumers new to a market, 37
J. H. Roberts, G. L. Urban (1988)
Modeling multiattribute utility, risk, and belief dynamics for new consumer durable brand choice, 34
K. Leffler (1981)
Persuasion or information? The economics of prescription drug advertising, 24
P. Manchanda, P. K. Chintagunta (2004)
Responsiveness of physician prescription behavior to sales force effort: An individual level analysis, 15
M. Hurwitz, R. Caves (1988)
Persuasion or information? Promotion and the shares of brand name and generic pharmaceuticals, 31
G. S. Crawford, M. Shum (2005)
Uncertainty and learning in pharmaceutical demand, 73
D. Ackerberg (2001)
Empirically distinguishing informative and persuasive effects of advertising, 32
G. Shaffer, J. Zhang (1995)
Competitive coupon targeting, 14
J. A. Rizzo (1999)
Advertising and competition in the ethical pharmaceutical industry: The case of antihypertensive drugs, 42
B. Anand, R. Shachar (2004)
Advertising, the matchmaker
T. Erdem, M. P. Keane (1996)
Decision making under uncertainty: Capturing dynamic brand choice processes in turbulent consumer goods markets, 15
R. J. Meyer, A. Sathi (1985)
A multiattribute model of consumer choice during product learning, 4
L. J. Parsons, P. Vanden Abeele (1981)
Analysis of sales call effectiveness, 18
W. A. Kamakura, B. S. Kossar, M. Wedel (2004)
Identifying innovators for the cross-selling of new products, 50
P. Manchanda, Y. Xie, N. Youn (2008)
The role of targeted communication and contagion in new product adoption, 27
S. Neslin (2001)
ROI analysis of pharmaceutical promotion (RAPP): An independent study
S. Chib, E. Greenberg (1995)
Understanding the Metropolis-Hastings algorithm, 49
D. Fudenberg, J. Tirole (2000)
Customer poaching and brand switching, 31
New product launches are often accompanied by extensive marketing communication campaigns. Firms' allocation decisions for these marketing communication expenditures have two dimensionsacross consumers and over time. This allocation problem is different relative to the problem of allocation of resources for existing products. In the case of new products, consumers are uncertain about their quality and learn about the products through marketing communication. Furthermore, different consumers may have different rates of learning about product quality; i.e., there may be heterogeneous learning. Thus, consumer responsiveness to marketing communication could vary along two dimensions. For each consumer, this responsiveness would vary over time, as she learns about product quality. Across consumers, there would be differences in responsiveness in each time period. For optimal allocation of marketing communication across both consumers and time, firms would need estimates of how consumer responsiveness varies across consumers and over time. Past studies have typically focused on one of these two dimensions in which responsiveness varies. They have either looked at heterogeneity in responsiveness across agents or the variation in responsiveness over time. In the context of new products, past research has looked at how consumer learning about product quality causes responsiveness to vary over time. In this study, we build a model that allows for heterogeneous learning rates and obtain individual-level learning parameters for each consumer. We use a novel and rich panel data set that allows us to estimate these model parameters. To obtain individual-level estimates of learning, we add a hierarchical Bayesian structure to the Bayesian learning model. We exploit the natural hierarchy in the Bayesian learning process to incorporate it in the hierarchical Bayesian model. We use data augmentation, coupled with the Metropolis-Hastings algorithm, to make inferences about individual-level parameters of learning. We conduct this analysis on a unique panel data set of physicians where we observe prescription decisions and detailing (i.e., sales-force effort) at the individual physician level for a new prescription drug category. Our results show that there is significant heterogeneity across physicians in their rates of learning about the quality of new drugs. We also find that there are asymmetries in the temporal evolution of responsiveness of physicians to detailingphysicians who are more responsive to detailing in early periods are less responsive later on and vice versa. These findings have interesting implications for the targeting of detailing across physicians and over time. We find that firms could increase their revenue if they took these temporal and cross-sectional differences in responsiveness into account while deciding on allocations of detailing.
Marketing Science – INFORMS
Published: May 21, 2009
Keywords: Keywords : resource allocation ; pharmaceutical markets ; learning models ; Markov chain Monte Carlo methods
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.